nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—MAP3K9—pancreas—sclerosing cholangitis	0.0552	0.069	CbGeAlD
Pazopanib—PDGFRA—gall bladder—sclerosing cholangitis	0.0403	0.0504	CbGeAlD
Pazopanib—SH2B3—pancreas—sclerosing cholangitis	0.039	0.0488	CbGeAlD
Pazopanib—MAP3K9—liver—sclerosing cholangitis	0.0352	0.0439	CbGeAlD
Pazopanib—KIT—gall bladder—sclerosing cholangitis	0.0322	0.0403	CbGeAlD
Pazopanib—PDGFRB—gall bladder—sclerosing cholangitis	0.0315	0.0393	CbGeAlD
Pazopanib—PI4KB—pancreas—sclerosing cholangitis	0.0289	0.0361	CbGeAlD
Pazopanib—TAOK1—liver—sclerosing cholangitis	0.0264	0.033	CbGeAlD
Pazopanib—PIP4K2C—pancreas—sclerosing cholangitis	0.0254	0.0317	CbGeAlD
Pazopanib—SH2B3—liver—sclerosing cholangitis	0.0248	0.031	CbGeAlD
Pazopanib—STK16—liver—sclerosing cholangitis	0.0211	0.0264	CbGeAlD
Pazopanib—LYN—liver—sclerosing cholangitis	0.0209	0.0261	CbGeAlD
Pazopanib—RIOK2—liver—sclerosing cholangitis	0.0208	0.026	CbGeAlD
Pazopanib—FGFR3—liver—sclerosing cholangitis	0.0208	0.026	CbGeAlD
Pazopanib—FLT1—pancreas—sclerosing cholangitis	0.0198	0.0248	CbGeAlD
Pazopanib—TAOK3—pancreas—sclerosing cholangitis	0.0187	0.0234	CbGeAlD
Pazopanib—STK36—liver—sclerosing cholangitis	0.0187	0.0233	CbGeAlD
Pazopanib—PI4KB—liver—sclerosing cholangitis	0.0184	0.023	CbGeAlD
Pazopanib—LIMK2—liver—sclerosing cholangitis	0.0181	0.0226	CbGeAlD
Pazopanib—FGFR3—NOTCH1 regulation of human endothelial cell calcification—ALPL—sclerosing cholangitis	0.0179	0.0897	CbGpPWpGaD
Pazopanib—FLT4—liver—sclerosing cholangitis	0.0162	0.0203	CbGeAlD
Pazopanib—PIP4K2C—liver—sclerosing cholangitis	0.0161	0.0202	CbGeAlD
Pazopanib—FGFR1—liver—sclerosing cholangitis	0.016	0.02	CbGeAlD
Pazopanib—MAP3K2—liver—sclerosing cholangitis	0.0153	0.0191	CbGeAlD
Pazopanib—KIT—pancreas—sclerosing cholangitis	0.0149	0.0186	CbGeAlD
Pazopanib—PDGFRB—pancreas—sclerosing cholangitis	0.0145	0.0181	CbGeAlD
Pazopanib—FGF1—liver—sclerosing cholangitis	0.0144	0.018	CbGeAlD
Pazopanib—LCK—liver—sclerosing cholangitis	0.0143	0.0179	CbGeAlD
Pazopanib—FGFR2—liver—sclerosing cholangitis	0.0136	0.017	CbGeAlD
Pazopanib—FLT1—liver—sclerosing cholangitis	0.0126	0.0158	CbGeAlD
Pazopanib—STK10—liver—sclerosing cholangitis	0.0119	0.0149	CbGeAlD
Pazopanib—TAOK3—liver—sclerosing cholangitis	0.0119	0.0149	CbGeAlD
Pazopanib—PDGFRA—liver—sclerosing cholangitis	0.0118	0.0148	CbGeAlD
Pazopanib—UGT1A1—liver—sclerosing cholangitis	0.0113	0.0141	CbGeAlD
Pazopanib—MAP2K5—liver—sclerosing cholangitis	0.0107	0.0133	CbGeAlD
Pazopanib—KDR—liver—sclerosing cholangitis	0.0107	0.0133	CbGeAlD
Pazopanib—CSF1R—liver—sclerosing cholangitis	0.0104	0.013	CbGeAlD
Pazopanib—KIT—liver—sclerosing cholangitis	0.00945	0.0118	CbGeAlD
Pazopanib—SLCO1B1—liver—sclerosing cholangitis	0.00939	0.0117	CbGeAlD
Pazopanib—PDGFRB—liver—sclerosing cholangitis	0.00923	0.0115	CbGeAlD
Pazopanib—FLT1—Angiogenesis—HIF1A—sclerosing cholangitis	0.00858	0.043	CbGpPWpGaD
Pazopanib—FLT1—VEGFR1 specific signals—HIF1A—sclerosing cholangitis	0.00738	0.0369	CbGpPWpGaD
Pazopanib—FGFR3—Endochondral Ossification—ALPL—sclerosing cholangitis	0.0062	0.031	CbGpPWpGaD
Pazopanib—KDR—Angiogenesis—HIF1A—sclerosing cholangitis	0.00571	0.0286	CbGpPWpGaD
Pazopanib—CYP2C8—liver—sclerosing cholangitis	0.00534	0.00667	CbGeAlD
Pazopanib—ABCG2—liver—sclerosing cholangitis	0.00519	0.00648	CbGeAlD
Pazopanib—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00503	0.0252	CbGpPWpGaD
Pazopanib—CYP1A2—liver—sclerosing cholangitis	0.00499	0.00624	CbGeAlD
Pazopanib—MAP3K2—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00497	0.0249	CbGpPWpGaD
Pazopanib—FGFR3—Neural Crest Differentiation—TCF4—sclerosing cholangitis	0.00469	0.0235	CbGpPWpGaD
Pazopanib—FGFR2—Angiogenesis—HIF1A—sclerosing cholangitis	0.00451	0.0226	CbGpPWpGaD
Pazopanib—MAP3K2—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00438	0.0219	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0043	0.0215	CbGpPWpGaD
Pazopanib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00421	0.0211	CbGpPWpGaD
Pazopanib—PDGFRA—Angiogenesis—HIF1A—sclerosing cholangitis	0.00419	0.021	CbGpPWpGaD
Pazopanib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00413	0.0207	CbGpPWpGaD
Pazopanib—ABCB1—pancreas—sclerosing cholangitis	0.00402	0.00503	CbGeAlD
Pazopanib—FGFR1—Endochondral Ossification—ALPL—sclerosing cholangitis	0.00398	0.0199	CbGpPWpGaD
Pazopanib—FGF1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00386	0.0193	CbGpPWpGaD
Pazopanib—CYP3A4—liver—sclerosing cholangitis	0.00361	0.00452	CbGeAlD
Pazopanib—CYP2D6—liver—sclerosing cholangitis	0.00356	0.00444	CbGeAlD
Pazopanib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00336	0.0168	CbGpPWpGaD
Pazopanib—KDR—Notch-mediated HES/HEY network—HIF1A—sclerosing cholangitis	0.00333	0.0167	CbGpPWpGaD
Pazopanib—MAP2K5—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00328	0.0164	CbGpPWpGaD
Pazopanib—FGFR2—Neural Crest Differentiation—TCF4—sclerosing cholangitis	0.00322	0.0161	CbGpPWpGaD
Pazopanib—FGFR1—Neural Crest Differentiation—TCF4—sclerosing cholangitis	0.00301	0.015	CbGpPWpGaD
Pazopanib—FGFR1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00298	0.0149	CbGpPWpGaD
Pazopanib—PDGFRA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00297	0.0149	CbGpPWpGaD
Pazopanib—MAP2K5—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.0029	0.0145	CbGpPWpGaD
Pazopanib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00259	0.013	CbGpPWpGaD
Pazopanib—ABCB1—liver—sclerosing cholangitis	0.00256	0.0032	CbGeAlD
Pazopanib—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00219	0.011	CbGpPWpGaD
Pazopanib—FGFR3—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00212	0.0106	CbGpPWpGaD
Pazopanib—LIMK2—Developmental Biology—TCF4—sclerosing cholangitis	0.002	0.01	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—ABCB4—sclerosing cholangitis	0.00191	0.00958	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.0019	0.0095	CbGpPWpGaD
Pazopanib—EPHB6—Developmental Biology—TCF4—sclerosing cholangitis	0.00188	0.0094	CbGpPWpGaD
Pazopanib—PDGFRA—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00186	0.00929	CbGpPWpGaD
Pazopanib—FGF1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00176	0.00883	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00176	0.00882	CbGpPWpGaD
Pazopanib—UGT1A1—Phase II conjugation—GGT1—sclerosing cholangitis	0.00176	0.0088	CbGpPWpGaD
Pazopanib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00169	0.00848	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00146	0.00731	CbGpPWpGaD
Pazopanib—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00146	0.00729	CbGpPWpGaD
Pazopanib—SH2B3—Hemostasis—NOS2—sclerosing cholangitis	0.00144	0.00721	CbGpPWpGaD
Pazopanib—LCK—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00144	0.00719	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00143	0.00718	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00136	0.00681	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00136	0.00679	CbGpPWpGaD
Pazopanib—LCK—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00132	0.00663	CbGpPWpGaD
Pazopanib—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00131	0.00654	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00126	0.00632	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00122	0.00612	CbGpPWpGaD
Pazopanib—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00119	0.00595	CbGpPWpGaD
Pazopanib—UGT1A1—NRF2 pathway—GGT1—sclerosing cholangitis	0.00117	0.00587	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—TCF4—sclerosing cholangitis	0.00115	0.00574	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00113	0.00563	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00105	0.00526	CbGpPWpGaD
Pazopanib—UGT1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.00103	0.00515	CbGpPWpGaD
Pazopanib—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00101	0.00507	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000981	0.00491	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000972	0.00487	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—GOT2—sclerosing cholangitis	0.000909	0.00455	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000883	0.00442	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000875	0.00438	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—TCF4—sclerosing cholangitis	0.000844	0.00423	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.0008	0.00401	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—GOT1—sclerosing cholangitis	0.000784	0.00393	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—GGT1—sclerosing cholangitis	0.000784	0.00393	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—TCF4—sclerosing cholangitis	0.000743	0.00372	CbGpPWpGaD
Pazopanib—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000706	0.00354	CbGpPWpGaD
Pazopanib—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.000644	0.00322	CbGpPWpGaD
Pazopanib—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000643	0.00322	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000597	0.00299	CbGpPWpGaD
Pazopanib—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	0.000542	0.00271	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000537	0.00269	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000526	0.00263	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000507	0.00254	CbGpPWpGaD
Pazopanib—FGFR3—Disease—GOT2—sclerosing cholangitis	0.000461	0.00231	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000456	0.00228	CbGpPWpGaD
Pazopanib—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.000445	0.00223	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ABCB4—sclerosing cholangitis	0.000429	0.00215	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000407	0.00204	CbGpPWpGaD
Pazopanib—FGFR3—Disease—GOT1—sclerosing cholangitis	0.000398	0.00199	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000397	0.00199	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ABCB4—sclerosing cholangitis	0.000393	0.00197	CbGpPWpGaD
Pazopanib—FGF1—Disease—GOT2—sclerosing cholangitis	0.000383	0.00192	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000379	0.0019	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.000377	0.00189	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000372	0.00186	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	0.000364	0.00182	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000362	0.00181	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000353	0.00177	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00034	0.0017	CbGpPWpGaD
Pazopanib—FGF1—Disease—GOT1—sclerosing cholangitis	0.000331	0.00166	CbGpPWpGaD
Pazopanib—FGFR2—Disease—GOT2—sclerosing cholangitis	0.000317	0.00159	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000313	0.00157	CbGpPWpGaD
Pazopanib—KIT—Disease—GOT2—sclerosing cholangitis	0.000311	0.00156	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000308	0.00154	CbGpPWpGaD
Pazopanib—FGFR1—Disease—GOT2—sclerosing cholangitis	0.000296	0.00148	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—GOT2—sclerosing cholangitis	0.000295	0.00148	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—NOS2—sclerosing cholangitis	0.000293	0.00147	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000292	0.00146	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000291	0.00146	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000291	0.00146	CbGpPWpGaD
Pazopanib—FGFR3—Disease—HIF1A—sclerosing cholangitis	0.000277	0.00139	CbGpPWpGaD
Pazopanib—FGFR2—Disease—GOT1—sclerosing cholangitis	0.000274	0.00137	CbGpPWpGaD
Pazopanib—KIT—Disease—GOT1—sclerosing cholangitis	0.000269	0.00135	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—GOT2—sclerosing cholangitis	0.000266	0.00133	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000263	0.00131	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000257	0.00129	CbGpPWpGaD
Pazopanib—FGFR1—Disease—GOT1—sclerosing cholangitis	0.000255	0.00128	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—GOT1—sclerosing cholangitis	0.000254	0.00127	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000254	0.00127	CbGpPWpGaD
Pazopanib—FGFR3—Disease—NOS2—sclerosing cholangitis	0.000252	0.00126	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—NOS2—sclerosing cholangitis	0.00024	0.0012	CbGpPWpGaD
Pazopanib—FGF1—Disease—HIF1A—sclerosing cholangitis	0.00023	0.00115	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—GOT1—sclerosing cholangitis	0.000229	0.00115	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	0.000226	0.00113	CbGpPWpGaD
Pazopanib—LCK—Disease—GOT2—sclerosing cholangitis	0.000213	0.00107	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000211	0.00105	CbGpPWpGaD
Pazopanib—FGF1—Disease—NOS2—sclerosing cholangitis	0.000209	0.00105	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000208	0.00104	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GOT2—sclerosing cholangitis	0.000204	0.00102	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000197	0.000985	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000194	0.000971	CbGpPWpGaD
Pazopanib—FGFR2—Disease—HIF1A—sclerosing cholangitis	0.00019	0.000953	CbGpPWpGaD
Pazopanib—KIT—Disease—HIF1A—sclerosing cholangitis	0.000187	0.000936	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GOT2—sclerosing cholangitis	0.000187	0.000935	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.000185	0.000928	CbGpPWpGaD
Pazopanib—LCK—Disease—GOT1—sclerosing cholangitis	0.000184	0.000921	CbGpPWpGaD
Pazopanib—FGFR1—Disease—HIF1A—sclerosing cholangitis	0.000177	0.000889	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—HIF1A—sclerosing cholangitis	0.000177	0.000886	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GOT1—sclerosing cholangitis	0.000176	0.000881	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GGT1—sclerosing cholangitis	0.000176	0.000881	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000173	0.000868	CbGpPWpGaD
Pazopanib—FGFR2—Disease—NOS2—sclerosing cholangitis	0.000173	0.000867	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GOT2—sclerosing cholangitis	0.000173	0.000866	CbGpPWpGaD
Pazopanib—KIT—Disease—NOS2—sclerosing cholangitis	0.00017	0.000852	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000169	0.000846	CbGpPWpGaD
Pazopanib—FGFR1—Disease—NOS2—sclerosing cholangitis	0.000161	0.000808	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GOT1—sclerosing cholangitis	0.000161	0.000807	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GGT1—sclerosing cholangitis	0.000161	0.000807	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000161	0.000807	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—NOS2—sclerosing cholangitis	0.000161	0.000806	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—HIF1A—sclerosing cholangitis	0.000159	0.000799	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000157	0.000787	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GGT1—sclerosing cholangitis	0.000149	0.000747	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GOT1—sclerosing cholangitis	0.000149	0.000747	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—NOS2—sclerosing cholangitis	0.000145	0.000726	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000145	0.000724	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000133	0.000668	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000131	0.000656	CbGpPWpGaD
Pazopanib—LCK—Disease—HIF1A—sclerosing cholangitis	0.000128	0.000641	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000124	0.000622	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000124	0.000621	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000121	0.000607	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS2—sclerosing cholangitis	0.000116	0.000583	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000112	0.000559	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000109	0.000547	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	0.000107	0.000537	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GOT2—sclerosing cholangitis	9.35e-05	0.000468	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	9.26e-05	0.000464	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	9.26e-05	0.000464	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HIF1A—sclerosing cholangitis	8.96e-05	0.000449	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	8.81e-05	0.000441	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GOT1—sclerosing cholangitis	8.07e-05	0.000404	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GGT1—sclerosing cholangitis	8.07e-05	0.000404	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	7.6e-05	0.000381	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	7.6e-05	0.000381	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	7.46e-05	0.000374	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	6.44e-05	0.000323	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	6.44e-05	0.000323	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	5.76e-05	0.000288	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	4.97e-05	0.000249	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	4.97e-05	0.000249	CbGpPWpGaD
